1-(n-Octyl)-3-nitro-1-nitrosoguanidin | 35799-08-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-(n-Octyl)-3-nitro-1-nitrosoguanidin
• 英文别名: N'-nitro-N-nitroso-N-octyl-guanidine；3-Nitro-1-nitroso-1-octylguanidine；3-nitro-1-nitroso-1-octylguanidine
• CAS: 35799-08-7
• 化学式: C₉H₁₉N₅O₃
• 分子量: 245.282
• InChiKey: AOZCQGYQFGAKBG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  17
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  117
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  辛胺 在 硝酸 、 sodium nitrite 作用下， 以 水 为溶剂， 生成 1-(n-Octyl)-3-nitro-1-nitrosoguanidin
  参考文献：
  名称：

  Reaction of Aromatic Heterocyclic Nitro Compounds with Potassium Cyanide. III. Some Nitroquinoline 1-Oxides

  摘要：

  3-硝基喹啉-1-氧化物与氰化钾在甲醇中反应，生成了3-甲氧基奎尼啶腈-1-氧化物（I）和3-甲氧基-1H-吡唑[4, 3-b]喹啉-9-羧酰胺（II）。5-硝基喹啉-1-氧化物生成了5-甲氧基喹啉-6-腈-1-氧化物（XIII）和7-氨基异噁唑[3, 4-f]喹啉-1-氧化物（XIV），而6-硝基喹啉-1-氧化物通过类似反应生成甲基5-氰基-6-甲氧基喹啉-1-氧化物（VI）、5-氰基-6-甲氧基喹啉酰胺-1-氧化物（VII）和1-羟基-6-硝基氨基苯乙烯（VIII）。4-硝基喹啉-1-氧化物产生了4-甲氧基喹啉-1-氧化物。

  DOI：

  10.1248/cpb.19.1809

文献信息

• AEROSOLIZED NITRITE AND NITRIC OXIDE - DONATING COMPOUNDS AND USES THEREOF
  申请人：Aires Pharmaceuticals, Inc.

  公开号：EP2237788A2

  公开（公告）日：2010-10-13
• AEROSOLIZED NITRITE AND NITRIC OXIDE -DONATING COMPOUNDS AND USES THEREOF
  申请人：Surber Mark W.

  公开号：US20090196930A1

  公开（公告）日：2009-08-06

  Disclosed herein are formulations of nitrite, nitrite salt, or nitrite- or nitric oxide-producing compounds suitable for aerosolization and use of such formulations for aerosol administration of nitrite, nitrite salt, or nitrite- or nitric oxide-donating compounds for the treatment of pulmonary arterial hypertension, intra-nasal or pulmonary bacterial infections, or to treat or prevent ischemic reperfusion injury of the heart, brain and organs involved in transplantation. In particular, inhaled nitrite, nitrite salt, or nitrite- or nitric oxide-donating compound specifically formulated and delivered to the respiratory tract for the indications is described. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures and manufacturing processes for production and use of the compositions described.
• AEROSOLIZED NITRITE AND NITRIC OXIDE-DONATING COMPOUNDS AND USES THEREOF
  申请人：AIRES PHARMACEUTICALS, INC.

  公开号：US20130028942A1

  公开（公告）日：2013-01-31

  Disclosed herein are formulations of nitrite, nitrite salt, or nitrite- or nitric oxide-producing compounds suitable for aerosolization and use of such formulations for aerosol administration of nitrite, nitrite salt, or nitrite- or nitric oxide-donating compounds for the treatment of pulmonary arterial hypertension, intra-nasal or pulmonary bacterial infections, or to treat or prevent ischemic reperfusion injury of the heart, brain and organs involved in transplantation. In particular, inhaled nitrite, nitrite salt, or nitrite- or nitric oxide-donating compound specifically formulated and delivered to the respiratory tract for the indications is described. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures and manufacturing processes for production and use of the compositions described.
• [EN] AEROSOLIZED NITRITE AND NITRIC OXIDE - DONATING COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS PERMETTANT D'OBTENIR DU NITRITE ET DE L'OXYDE NITRIQUE AÉROSOLISÉS ET LEURS UTILISATIONS
  申请人：AIRES PHARMACEUTICALS INC

  公开号：WO2009086470A2

  公开（公告）日：2009-07-09

  Disclosed herein are formulations of nitrite, nitrite salt, or nitrite- or nitric oxide-producing compounds suitable for aerosolization and use of such formulations for aerosol administration of nitrite, nitrite salt, or nitrite- or nitric oxide-donating compounds for the treatment of pulmonary arterial hypertension, intra-nasal or pulmonary bacterial infections, or to treat or prevent ischemic reperfusion injury of the heart, brain and organs involved in transplantation. In particular, inhaled nitrite, nitrite salt, or nitrite- or nitric oxide-donating compound specifically formulated and delivered to the respiratory tract for the indications is described. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures and manufacturing processes for production and use of the compositions described.
• Reaction of Aromatic Heterocyclic Nitro Compounds with Potassium Cyanide. III. Some Nitroquinoline 1-Oxides
  作者：TOSHIHIKO OKAMOTO、HIROSHI TAKAHASHI

  DOI：10.1248/cpb.19.1809

  日期：——

  The reaction of 3-nitroquinoline 1-oxide with potassium cyanide in methanol was carried out producing 3-methoxycinchoninonitrile 1-oxide (I) and 3-methoxy-1H-pyrazolo [4, 3-b] quinoline-9-carboxamide (II). 5-Nitroquinoline 1-oxide gave 5-methoxyquinoline-6-carbonitrile 1-oxide (XIII) and 7-aminoisoxazolo [3, 4-f] quinoline 1-oxide (XIV), whereas 6-nitroquinoline 1-oxide gave methyl 5-cyano-6-methoxyquinaldimidate 1-oxide (VI), 5-cyano-6-methoxyquinaldamide 1-oxide (VII), and 1-hydroxy-6-nitrocarbostyril (VIII) by the similar type reactions. 4-Nitroquinoline 1-oxide produced 4-methoxyquinoline 1-oxide.

  3-硝基喹啉-1-氧化物与氰化钾在甲醇中反应，生成了3-甲氧基奎尼啶腈-1-氧化物（I）和3-甲氧基-1H-吡唑[4, 3-b]喹啉-9-羧酰胺（II）。5-硝基喹啉-1-氧化物生成了5-甲氧基喹啉-6-腈-1-氧化物（XIII）和7-氨基异噁唑[3, 4-f]喹啉-1-氧化物（XIV），而6-硝基喹啉-1-氧化物通过类似反应生成甲基5-氰基-6-甲氧基喹啉-1-氧化物（VI）、5-氰基-6-甲氧基喹啉酰胺-1-氧化物（VII）和1-羟基-6-硝基氨基苯乙烯（VIII）。4-硝基喹啉-1-氧化物产生了4-甲氧基喹啉-1-氧化物。